Skip to main content

Incoming CVS Health President and CEO reacts to President-Elect Biden’s COVID-19 update

January 15, 2021 | Public Policy

WOONSOCKET, R.I. — The following is attributed to Karen S. Lynch, currently Executive Vice President, CVS Health and President, Aetna, who will become the company's next President and CEO on February 1:

“We agree with President-elect Biden that pharmacies will play a critical role in the next phase of the COVID-19 vaccine rollout and appreciate his leadership in the pandemic response. CVS Health has more than 90,000 trained health care professionals standing by, with the capacity to administer approximately one million shots per day through our 10,000 CVS Pharmacy locations across the country once the federal program is fully activated. This will build on our success in providing vaccines to one of the nation’s most vulnerable populations, having administered more than one million shots at long-term care facilities to date.

“We also agree that despite the growing availability of vaccines, wearing a mask, maintaining safe distances and avoiding crowds remain the best ways to slow the spread. These guidelines are based on sound science and will be critical for months to come.”

About CVS Health

CVS Health is a different kind of health care company. We are a diversified health services company with nearly 300,000 employees united around a common purpose of helping people on their path to better health. In an increasingly connected and digital world, we are meeting people wherever they are and changing health care to meet their needs. Built on a foundation of unmatched community presence, our diversified model engages one in three Americans each year. From our innovative new services at HealthHUB® locations, to transformative programs that help manage chronic conditions, we are making health care more accessible, more affordable and simply better. Learn more about how we're transforming health at

Media contact

T.J. Crawford